You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Mycophenolic Acid tablets are indicated for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,Mycophenolic Acid tablets are indicated for induction and maintenance treatment of adult patients with WHO Class III, IV or V lupus nephritis.,This indication is based on the evidence in literature reports of studies of treatment in patients with lupus nephritis, the majority of whom were ISN/RPS (2003) Class IV. The evidence for efficacy was based on surrogate endpoints.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Mycophenolic Acid tablets are indicated for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,Mycophenolic Acid tablets are indicated for induction and maintenance treatment of adult patients with WHO Class III, IV or V lupus nephritis.,This indication is based on the evidence in literature reports of studies of treatment in patients with lupus nephritis, the majority of whom were ISN/RPS (2003) Class IV. The evidence for efficacy was based on surrogate endpoints.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Mycophenolic Acid tablets are indicated for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,Mycophenolic Acid tablets are indicated for induction and maintenance treatment of adult patients with WHO Class III, IV or V lupus nephritis.,This indication is based on the evidence in literature reports of studies of treatment in patients with lupus nephritis, the majority of whom were ISN/RPS (2003) Class IV. The evidence for efficacy was based on surrogate endpoints.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Mycophenolic Acid tablets are indicated for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,Mycophenolic Acid tablets are indicated for induction and maintenance treatment of adult patients with WHO Class III, IV or V lupus nephritis.,This indication is based on the evidence in literature reports of studies of treatment in patients with lupus nephritis, the majority of whom were ISN/RPS (2003) Class IV. The evidence for efficacy was based on surrogate endpoints.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Mycophenolic Acid tablets are indicated for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,Mycophenolic Acid tablets are indicated for induction and maintenance treatment of adult patients with WHO Class III, IV or V lupus nephritis.,This indication is based on the evidence in literature reports of studies of treatment in patients with lupus nephritis, the majority of whom were ISN/RPS (2003) Class IV. The evidence for efficacy was based on surrogate endpoints.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Mycophenolic Acid tablets are indicated for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,Mycophenolic Acid tablets are indicated for induction and maintenance treatment of adult patients with WHO Class III, IV or V lupus nephritis.,This indication is based on the evidence in literature reports of studies of treatment in patients with lupus nephritis, the majority of whom were ISN/RPS (2003) Class IV. The evidence for efficacy was based on surrogate endpoints.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Mycophenolic Acid tablets are indicated for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,Mycophenolic Acid tablets are indicated for induction and maintenance treatment of adult patients with WHO Class III, IV or V lupus nephritis.,This indication is based on the evidence in literature reports of studies of treatment in patients with lupus nephritis, the majority of whom were ISN/RPS (2003) Class IV. The evidence for efficacy was based on surrogate endpoints.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
